Page 1

cegedim PRESS RELEASE First - half financial information as of June 30 , 2026 IFRS - Regulated information - Not audited First - half 2026 results : profitability continues to improve • Adjusted EBITDA ( 1 ) of € 62.0 million , equal to 19.1 % of revenue . Adjusted operating income ( 1 ) of € 19.7 million , up 6.9 % Operating income of € 17.3 million , up 82.9 % Boulogne - Billancourt , France , September 24 , 2026 , after the market close Cegedim generated consolidated H1 2026 revenue of € 324.8 million , a + 0.8 % year - on - year organic growth , and adjusted EBITDA ( 1 ) of € 62.0 million , up € 0.8 million or + 1.3 % . Adjusted operating margin ( 1 ) came to 6.1 % compared with 5.7 % at June 30 , 2025 . Operating income came to € 17.3 million , a € 7.8 million or + 82.9 % increase . Artificial intelligence lies at the heart of the Cegedim Group's strategy , which is structured around three key areas . Al is equipping the Group's development factory to boost R & D productivity while optimizing its use through cost - efficiency monitoring . The Group is developing Al tools to improve its internal productivity , notably for case handlers in the Payroll and Insurance BPO businesses as well as in customer support . Lastly , Cegedim aims to enrich its client offering by rolling out Al features , as it already does with the Maiia suite , the Claude Bernard Database , the HR business , and fraud detection in Third - party payer . H1 2026 HT 2025 Change In Єm In % In Єm In % In € m In % Revenue 324.8 100 % 322.5 100 % +2.3 + 0.7 % Adjusted EBITDA ( 1 ) 62.0 19.1 % 61.2 19.0 % +0.8 + 1.3 % Depreciation and amortization expenses -42.3 -42.7 +0.4 -1.1 % Adjusted operating income ( 1 ) 19.7 6.1 % 18.5 5.7 % +1.2 + 6.9 % Specific income and expenses affecting operating -1.3 -1.6 +0.3 -17.5 % income Non - recurring income and expenses -1.1 -7.4 +6.3 -84.8 % Operating income 17.3 5.3 % 9.5 2.9 % +7.8 + 82.9 % Net financial income ( expense ) -9.6 -8.3 -1.3 + 16.2 % Total tax -3.5 -1.0 -2.5 + 266.6 % Net profit ( loss ) from affiliates 0.0 -0.1 -0.1 Consolidated net profit 4.2 1.3 % 0.1 0.0 % +4.1 Non - controlling interest -1.2 -1.1 -0.1 + 16.0 % Group share 5.4 1.7 % 1.2 0.4 % +4.2 Adjusted earnings per share ( 1 ) ( in euros ) 0.4 0.2 Earnings per share ( in euros ) 0.4 0.1 Consolidated revenue rose € 2.3 million , or + 0.7 % , to € 324.8 million in H1 2026 compared with € 322.5 million in 2025. The positive scope effect of € 0.2 million , or + 0.1 % , was attributable to the acquisition of Médoucine and its consolidation into the accounts as of May 1 , 2026. The currency impact was negative at € 0.5 million , or -0.2 % , chiefly owing to the depreciation of the pound sterling . On an organic basis , revenue grew € 2.6 million , or + 0.8 % , over the period . The strongest contributions to growth for the half came from the Business Services businesses in France ( HR and e - business ) , the Third - party payer business in health insurance , as well as the Group's international subsidiaries in the Business Units Health & Provident Insurance and Healthcare Professionals . ( 1 ) Alternative performance indicator . See pages 117 to 120 of the 2025 Universal Registration Document . Cegedim 137 rue d'Aguesseau , 92100 Boulogne - Billancourt Tel .: +33 ( 0 ) 1 49 09 22 00 www.cegedim.fr SA ( corporation ) with capital of € 13,431,769.27 SIRET 350 422 622 00141 R. C. S. Nanterre B 350 422 622 Page 1